hat
Flibanserin yo itilize pou trete fanm ki gen maladi ipoektif dezi seksyèl (HSDD; yon dezi seksyèl ki lakòz difikilte oswa difikilte interpersonal) ki pa gen eksperyans menopoz (chanjman nan lavi; nan fen peryòd règ chak mwa). Flibanserin pa ta dwe itilize pou tretman HSDD nan fanm ki te ale nan menopoz oswa nan gason oswa pou amelyore pèfòmans seksyèl. Flibanserin se nan yon klas nan medikaman ki rele yon reseptè serotonin 1A agonist / serotonin reseptè 2A antagonist. Li travay pa chanje aktivite a nan serotonin ak lòt sibstans natirèl nan sèvo a.
eng
Flibanserin is used to treat women with hypoactive sexual desire disorder (HSDD; a low sexual desire that causes distress or interpersonal difficulty) who have not experienced menopause (change of life; the end of monthly menstrual periods). Flibanserin should not be used for the treatment of HSDD in women who have gone through menopause or in men or to improve sexual performance. Flibanserin is in a class of medications called a serotonin receptor 1A agonist/serotonin receptor 2A antagonist. It works by changing the activity of serotonin and other natural substances in the brain.